| | | | | Swiss drugmaker Novartis is "completely committed" to its $10 billion-per-year Sandoz generics business, a spokesman said on Thursday, after a newspaper reported Chief Executive Vas Narasimhan planned to split the unit off. | | |
| | | Lack of staff now represents a bigger challenge to Britain's health service than funding and the system could face a 350,000 personnel shortage by 2030, leading health thinktanks warned on Thursday. | | |
| | | China's agricultural ministry said on Thursday it had confirmed a new African swine fever outbreak near the city of Huangguang in the central province of Hubei. | | |
| | | London's low emission traffic zone has modestly reduced residents' exposure to diesel engine pollution, but the better air quality has not brought improved lung health among the capital's children, research found on Wednesday. | | |
| | | (Reuters Health) - Infants who don't sleep through the night don't seem to be at higher risk for cognitive or motor development problems, a Canadian study suggests. | | |
| | | (Reuters Health) - Surgeries in poorer countries can become dangerous when electrical power goes out, as it often does. | | |
| | | (Reuters Health) - Patches containing nitroglycerin may help patients with common injuries to tendons, a research review suggests. | | |
| | | A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said. | | |
| | | Pfizer lost the final round in a lengthy patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica, exposing the company to possible financial claims. | | |
| | | (Reuters Health) - Twice as many U.S. children die from gunshot wounds in states with lax gun laws, compared to those with stricter rules, researchers told the annual conference of the American Academy of Pediatrics in Orlando, Florida. | | |
| | | French drugmaker Ipsen plans to bring in multiple new medicines through a series of transactions and sees the recent price drop of biotech stocks as increasing deal opportunities, its chief executive said on Wednesday. | | |
|
| |
